Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Rosetta Genomics Ltd. buy melinda

Start price
€1.33
17.05.17 / 50%
Target price
€1.80
25.05.17
Performance (%)
38.52%
End price
€1.85
25.05.17
Summary
This prediction ended on 25.05.17 with a price of €1.85. The BUY prediction by melinda for Rosetta Genomics Ltd. saw massive gains of 38.52%. melinda has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Rosetta Genomics Ltd. - - - -
iShares Core DAX® 1.560% 4.721% 18.671% 17.397%
iShares Nasdaq 100 0.517% 1.171% 23.619% 35.896%
iShares Nikkei 225® 1.730% 6.073% 16.253% 10.295%
iShares S&P 500 1.482% 1.218% 23.290% 38.843%

Comments by melinda for this prediction

In the thread Rosetta Genomics Ltd. diskutieren
Prediction Buy
Perf. (%) 38.52%
Target price 1.804
Change
Ends at 25.05.17

Gesundheit | Medical Laboratories & Forschung | Israel

hat $

Prediction Buy
Perf. (%) 38.52%
Target price 1.804
Change
Ends at 25.05.17

(Zielkurs erreicht)

Stopped prediction by melinda for Rosetta Genomics Ltd.

buy
Rosetta Genomics Ltd.

Start price
Target price
Perf. (%)
€0.97
03.10.17
€1.35
27.12.17
-48.91%
27.12.17

buy
Rosetta Genomics Ltd.

Start price
Target price
Perf. (%)
€1.08
03.10.17
€1.50
27.12.17
-48.91%
27.12.17

buy
Rosetta Genomics Ltd.

Start price
Target price
Perf. (%)
€2.40
07.04.17
€3.61
17.05.17
-40.39%
17.05.17